ARTICLE | Clinical News
EchoGen emulsion ultrasound contrast agent: SNUS completed enrollment in its 244-patient Phase III trial.
March 18, 1996 8:00 AM UTC
Analysis of the data is expected within three months. SNUS plans to file an NDA in the third quarter. ...